Tensor Surgical
Private Company
Total funding raised: $18.2M
Overview
Tensor Surgical is a private medical device innovator commercializing an anchorless, arthroscopic transosseous system for rotator cuff repair and biceps tenodesis. Founded in 2017 and based in Nashville, the company's technology eliminates suture anchors to reduce implant costs, avoid anchor-related complications, and purportedly enhance healing through improved biomechanics and blood flow. It targets the large orthopedic repair market by offering a clinically superior and economically attractive alternative to traditional anchor-based techniques, supported by Level I evidence and surgeon testimonials.
Technology Platform
Proprietary arthroscopic transosseous repair system (TransOs Tunneler) enabling anchorless soft tissue repair by creating bone tunnels for suture passage, eliminating the need for suture anchors.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Tensor Surgical directly competes with the dominant suture anchor-based repair systems from giants like Arthrex, Smith & Nephew, Stryker, and Johnson & Johnson's DePuy Synthes. Its competition is based on a paradigm shift (anchorless vs. anchored) rather than a direct feature-for-feature comparison. Other companies may be exploring similar transosseous or anchorless techniques, but Tensor appears to be a focused commercial leader in this niche.